Karina Vargová

5-Azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity

Pavel Burda, Karina Vargová, Vít Pospíšil et al. · Leukemia · 2012 · 44 citations

Life Sciences, Genetics, Molecular Biology +15

Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice

Petra Bašová, Vít Pospíšil, Filipp Savvulidi et al. · Oncogene · 2013 · 27 citations

Medicine, Hematology, Oncology +13

Oncogenic microRNA-155 and its target PU.1: an integrative gene expression study in six of the most prevalent lymphomas

Hana Hušková, Katarina Korecka, Josef Karban et al. · International Journal of Hematology · 2015 · 22 citations

Medicine, Cancer Biology, Oncology +15

Modeling cancer driver events in vitro using barrier bypass-clonal expansion assays and massively parallel sequencing

Hana Hušková, Maude Ardin, Annette Weninger et al. · Oncogene · 2017 · 14 citations · Full text

Life Sciences, Genetics, Oncology +17

Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways

Ľubomír Minařík, Kristýna Pimková, Juraj Kokavec et al. · Cells · 2022 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17